default image
Multi-cell loaded 3D printed stent
Silicon-based biomaterials enable low-cost and efficient multicellular 3D printing and promote tissue regeneration.
Type
Materials
Tags
Basic medicine
Biology
Life and health
3 d printing technology
Multi-cell 3d printing
Precise control of spatial distribution
Highly biomimetic
Tissue engineering
Solution maturity
Development / Pilot validation
Cooperation methods
Face-to-face consultation
Applicable industry
Scientific research and technology services
Applications
Medical biomanufacturing
Key innovations
The innovation of this product lies in using silicon-based biomaterials to achieve stable release of active ions, low-cost and efficient control of biological functions in the multi-cell 3D printing process, and enhancing inter-cell interactions. It has established a research and development platform and cooperation model, and has small-scale production capabilities.
Potential economic benefits
Multisar 3D printing technology can accurately regulate cell distribution and is used in tissue engineering and other fields, with huge market potential. After solving the problem of growth factors, it can regulate cell functions efficiently and efficiently at low cost, promote cell survival, proliferation and differentiation, and enhance interactions between multiple cells.
Potential climate benefits
Although multi-cell 3D printing has no direct carbon reduction benefits, its precise regulation and efficient application can reduce resource waste, such as reducing resource consumption caused by drug screening failures, promoting the development of the medical field, and indirectly helping to reduce carbon.
Solution supplier
View more
Shanghai Institute of Silicate, Chinese Academy of Sciences
Shanghai Institute of Silicate, Chinese Academy of Sciences
The Shanghai Institute of Silicate, Chinese Academy of Sciences, focuses on the research of advanced inorganic materials and supports high-tech industries and major national needs.
Shanghai,China
Solution details

Application areas:

Multiscell 3D printing is currently a hot topic in international research. Through precise regulation of the spatial distribution of multiple cells in the scaffold based on 3D printing technology, it is expected to achieve a high degree of biomimetic of human tissues and be used for tissue engineering, drug screening, tissue repair, etc., and has huge market potential with broad application prospects.

Technical characteristics:

Growth factors are needed in most multicellular 3D printing processes, and the sustainability, stability and cost control of growth factors are currently difficult to solve and a pain point in the practical application of this technology. Through the design of silicon-based biomaterials, the research team achieved the continuous and stable release of active ions, thereby achieving efficient control of key biological functions such as cell survival, proliferation and differentiation during the multi-cell 3D printing process at low cost., in particular, effective enhancement of multi-cell interactions is achieved.

Performance indicators:

By accurately controlling the composition and microscopic appearance of the silicon-based biomaterial in the cell carrier material, normal survival (more than 90%) and proliferation of cells within the cell can be achieved for a long time, and cell differentiation can be significantly promoted and multi-cell interactions can be enhanced.

Current status:
At present, the project team has an independent R & D platform in Changning District, Shanghai, and has established a complete system covering material R & D-physical and chemical testing-biological evaluation. Together with cooperative clinical hospitals, it has established tissue defect models for large animals such as goats. The project team currently has pilot production capabilities.

Last updated
11:14:31, Nov 04, 2025
Information contributed by

See original page on

Report